COVID‑19 in China: From epidemiology to treatment (Review)

  • Chen H
  • Wu S
  • Zhang X
N/ACitations
Citations of this article
84Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease caused by the novel coronavirus SARS-CoV-2. It first became prevalent in Wuhan, Hubei, China in December 2019. COVID-19 was initially characterized by pneumonia of unknown etiology, accompanied by fever, dry cough and fatigue. Due to its highly infectious nature it rapidly led to widespread human infection, causing 80,924 confirmed cases and 3,140 mortalities in mainland China as of March 9, 2020. The present review highlights the prevalence of COVID-19 in China, the etiology, pathology, clinical presentation, labora- tory and chest imaging tests, and treatment of this disease.Copyright © 2020 Spandidos Publications. All rights reserved.

Cite

CITATION STYLE

APA

Chen, H., Wu, S., & Zhang, X. (2020). COVID‑19 in China: From epidemiology to treatment (Review). Experimental and Therapeutic Medicine, 20(6), 1–1. https://doi.org/10.3892/etm.2020.9353

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free